Engineer Immune Cells via Chemoenzymatic Glycan Editing
Engineer Immune Cells via Chemoenzymatic Glycan Editing
批准号:
10350593
负责人:
John Ross Teijaro
金额:
$94.43万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-01 至 2024-02-29
关键词:
Adoptive Cell TransfersAntibodiesAntigensBLR1 geneBiological ProcessBiopolymersBiotinBiotinylationCD8-Positive T-LymphocytesCell CommunicationCell LineCell TherapyCell surfaceCellsChronicChronic Lymphocytic LeukemiaCytotoxic T-LymphocytesDendritic CellsDevelopmentEmbryonic DevelopmentEngineeringEnzymesFlow CytometryFucoseFucosyltransferaseFundingGlycocalyxGoalsHelicobacter pyloriHematologic NeoplasmsImmuneImmune System DiseasesImmune responseImmunoglobulin FragmentsLabelLymphomaMalignant NeoplasmsMediatingMembraneMethodsModelingMonoclonal AntibodiesMusNatural Killer CellsNeoplasm MetastasisPolysaccharidesPopulationProcessSignal TransductionSpecificityT-LymphocyteTumor AntigensTumor ImmunityViral CancerVirus Diseasesanti-PD-1/PD-L1anti-PD-L1anti-PD-L1 therapybasecell typechimeric antibodychimeric antigen receptor T cellscytotoxicdisorder preventionexhaustexhaustiongalactoside 3-fucosyltransferaseglycosyltransferasehuman diseaseimmune activationimmunoengineeringin vivointerestmigrationmouse modelnanobodiesneurotransmissionsuccesssugarsugar nucleotidetooltumortumor eradication
中文摘要
项目总结/摘要
细胞-细胞相互作用涉及许多生物过程,包括免疫反应,
胚胎发育、神经元信号传导和癌症转移。我们在理解上的一些主要差距
细胞间的相互作用包括:什么是一个特定的细胞类型在不同阶段的相互作用伙伴,
生物过程?如何改变这些相互作用的伙伴的细胞表面景观来调节功能
一种特定的细胞类型,其内源性功能的干扰最小?
本项目的目标是开发基于糖基转移酶的化学酶促方法,
将生物聚合物,包括酶和单克隆抗体,结合到细胞表面,以研究这些
谜题
在本项目的目标1中,我们将鉴定或设计一种混杂糖基转移酶,
将生物聚合物官能化的非天然糖从相应的核苷酸糖供体转移到细胞表面
目的细胞的糖萼。当生物聚合物是酶时,它将使得邻近依赖性聚合物能够被聚合。
标记与含有酶的感兴趣的细胞(诱饵细胞)相互作用的猎物细胞,条件是
被捕食细胞的细胞表面表达被酶修饰的底物。随后,信号
可以通过流式细胞术离体检测和分析通过标记产生的细胞。在目标1d和目标2中,我们
将使用小鼠模型将这种方法应用于体内探测细胞-细胞相互作用。重点将是
在免疫活化和T细胞免疫应答过程中识别特定免疫细胞类型的相互作用伴侣
衰竭(T细胞衰竭是T细胞逐渐失去功能的过程)。最后我们
将在目标3中开发一种方法,将单克隆抗体结合到免疫细胞上,
具体的瞄准能力。修饰细胞的迁移和抗肿瘤功效将在
小鼠肿瘤模型。
英文摘要
PROJECT SUMMARY/ABSTRACT
Cell-cell interactions are involved in numerous biological processes, including immune responses,
embryonic development, neuronal signaling and cancer metastasis. Some major gaps in our understanding of
cell-cell interactions include: what are the interacting partners of a specific cell type at different stages of a
biological process? How to modify the cell-surface landscape of these interacting partners to tune the functions
of a specific cell type with minimum perturbation of its endogenous functions?
The objective of this project is to develop glycosyltransferase-based chemoenzymatic methods to
incorporate biopolymers, including enzymes and monoclonal antibodies, onto the cell surface to study these
puzzles.
In Aim 1 of this project, we will identify or engineer a promiscuous glycosyltransferase that can transfer
biopolymer-functionalized unnatural sugars from the corresponding nucleotide sugar donors to the cell-surface
glycocalyx of the cells of interest. When the bioploymer is an enzyme, it will enable the proximity-dependent
labeling of prey cells that interact with the cells of interest (bait cells) that harbor the enzyme, providing that the
cell surface of prey cells expresses the substrates to be modified by the enzyme. Subsequently, the signal
generated by the labeling can be detected and analyzed ex vivo by flow cytometry. In Aim 1d and Aim 2, we
will apply this method to probe cell-cell interactions in vivo using mouse models. The focus will be the
identification of interacting partners of specific immune cell types during immune activation and T-cell
exhaustion (T-cell exhaustion is the process during which T cells progressively lose their functions). Finally, we
will develop a method in Aim 3 to conjugate monoclonal antibodies onto immune cells to endow them with
specific targeting capabilities. The migration and anti-tumor efficacy of the modified cells will be evaluated in
mouse tumor models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Animal and Organoid Model Core
-
批准号:10514322
-
项目类别:
-
资助金额:$365.76万
-
财政年份:2022
-
负责人:John Ross Teijaro
-
依托单位:
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
-
批准号:10445313
-
项目类别:
-
资助金额:$53.76万
-
财政年份:2021
-
负责人:John Ross Teijaro
-
依托单位:
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
-
批准号:10316578
-
项目类别:
-
资助金额:$53.76万
-
财政年份:2021
-
负责人:John Ross Teijaro
-
依托单位:
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
-
批准号:10650747
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2021
-
负责人:John Ross Teijaro
-
依托单位:
Engineer Immune Cells via Chemoenzymatic Glycan Editing
-
批准号:10578671
-
项目类别:
-
资助金额:$94.43万
-
财政年份:2019
-
负责人:John Ross Teijaro
-
依托单位:
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection
-
批准号:9204389
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2016
-
负责人:John Ross Teijaro
-
依托单位:
Novel Strategies for Controlling Persistent Viral Infection
-
批准号:9077410
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2016
-
负责人:John Ross Teijaro
-
依托单位:
Novel Strategies for Controlling Persistent Viral Infection
-
批准号:9248857
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2016
-
负责人:John Ross Teijaro
-
依托单位:
The Role of IL-27 in Controlling Persistent Viral Infection
-
批准号:8897666
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2014
-
负责人:John Ross Teijaro
-
依托单位:
海外基金